Detalhe da pesquisa
1.
Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells.
Blood
; 112(7): 2896-905, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18660379
2.
Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.
Clin Cancer Res
; 13(16): 4882-90, 2007 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17699868
3.
Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells.
Clin Cancer Res
; 12(19): 5869-78, 2006 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17020995
4.
Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Mol Cancer Ther
; 5(12): 3096-104, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17172412
5.
Understanding HTLV-I protease.
Chem Biol
; 10(5): 373-80, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12770819
6.
The 10 C-terminal residues of HTLV-I protease are not necessary for enzymatic activity.
Biochem Biophys Res Commun
; 320(4): 1306-8, 2004 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-15303275